These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8968297)

  • 21. Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients.
    Werner CU; Linde K; Schäffner J; Storr C; Schneider A
    NPJ Prim Care Respir Med; 2017 Dec; 27(1):64. PubMed ID: 29222436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is circadian variation in asthma severity relevant in the emergency department?
    Karras DJ; D'Alonzo GE; Heilpern KL
    Ann Emerg Med; 1995 Nov; 26(5):558-62. PubMed ID: 7486362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and mood.
    Apter AJ; Affleck G; Reisine ST; Tennen HA; Barrows E; Wells M; Willard A; ZuWallack RL
    J Allergy Clin Immunol; 1997 May; 99(5):605-12. PubMed ID: 9155825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring asthma control. Clinic questionnaire or daily diary?
    Juniper EF; O'Byrne PM; Ferrie PJ; King DR; Roberts JN
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1330-4. PubMed ID: 11029340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of asthma severity on symptom perception in childhood asthma.
    Cabral AL; Conceição GM; Saldiva PH; Martins MA
    Braz J Med Biol Res; 2002 Mar; 35(3):319-27. PubMed ID: 11887209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lifestyle changes in mild asthma during intermittent symptom-related use of terbutaline inhaled via 'Turbohaler'.
    Northfield M; Patel RK; Richardson A; Taylor MD; Richardson PD
    Curr Med Res Opin; 1991; 12(7):441-9. PubMed ID: 1778086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between symptoms and objective measures of airway obstruction in asthmatic patients.
    Liam CK; Goh CT; Isahak M; Lim KH; Wong CM
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):79-83. PubMed ID: 11699724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of asthma in adolescents and young adults: which objective measure is best?
    Ulrik CS; Postma DS; Backer V
    J Asthma; 2005 Sep; 42(7):549-54. PubMed ID: 16169787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized clinical trial of magnesium sulphate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks.
    Kokturk N; Turktas H; Kara P; Mullaoglu S; Yilmaz F; Karamercan A
    Pulm Pharmacol Ther; 2005; 18(6):416-21. PubMed ID: 15953743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asthma symptoms, morbidity, and antiinflammatory use in inner-city children.
    Warman KL; Silver EJ; Stein RE
    Pediatrics; 2001 Aug; 108(2):277-82. PubMed ID: 11483788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of peak expiratory flow rate variability for the diagnosis of asthma.
    Jamison JP; McKinley RK
    Clin Sci (Lond); 1993 Sep; 85(3):367-71. PubMed ID: 8403810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations between pulse oximetry and peak expiratory flow in acute asthma.
    Ribeiro de Andrade C; Duarte MC; Camargos P
    Braz J Med Biol Res; 2007 Apr; 40(4):485-90. PubMed ID: 17401491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
    Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asthma self-management education program by home monitoring of peak expiratory flow.
    Ignacio-Garcia JM; Gonzalez-Santos P
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):353-9. PubMed ID: 7842191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler.
    Möller M; Fritsche D; Rivera D; Libertus H
    Arzneimittelforschung; 2003; 53(8):562-7. PubMed ID: 13677246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate.
    Hetzel MR; Clark TJ
    Thorax; 1980 Oct; 35(10):732-8. PubMed ID: 7466721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spirometric patterns in childhood asthma: peak flow compared with other indices.
    Klein RB; Fritz GK; Yeung A; McQuaid EL; Mansell A
    Pediatr Pulmonol; 1995 Dec; 20(6):372-9. PubMed ID: 8649917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peak expiratory flow rate and premenstrual symptoms in healthy nonasthmatic women.
    Chong E; Ensom MH
    Pharmacotherapy; 2000 Dec; 20(12):1409-16. PubMed ID: 11130212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the pulmonary score: an asthma severity score for children.
    Smith SR; Baty JD; Hodge D
    Acad Emerg Med; 2002 Feb; 9(2):99-104. PubMed ID: 11825832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The peak flow meter: limited role in the diagnosis and follow-up of children with asthma].
    Kamps AW; Roorda RJ; Brand PL
    Ned Tijdschr Geneeskd; 2002 May; 146(18):842-6. PubMed ID: 12038221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.